Glutathione Synthetase (GSS)

📖 Wiki Page

protein1083 wordssynced 2026-04-02

Glutathione Synthetase (GSS)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Glutathione Synthetase (GSS)</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Glutathione Synthetase</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[GSS](/genes/gss)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P16455" target="_blank">P16455</a></td>
</tr>
<tr>
<td class="label">PDB ID</td>
<td>1GSA, 1GSH, 2GSS</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>52 kDa (474 amino acids)</td>
</tr>
<tr>
<td class="label">Subunit Structure</td>
<td>Homodimer (2 × 52 kDa)</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Cytosol, mitochondria</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>ATP-grasp fold family</td>
</tr>
<tr>
<td class="label">Brain Expression</td>
<td>High in hippocampus, cortex, cerebellum</td>
</tr>
</table>

Glutathione Synthetase (GSS)

Overview

Glutathione Synthetase (GSS) is the second and final enzyme in the biosynthesis of glutathione (GSH), the most abundant cellular antioxidant. GSS catalyzes the ATP-dependent conversion of γ-glutamylcysteine and glycine to form glutathione, completing the two-step biosynthesis pathway that begins with glutamate-cysteine ligase (GCL, also known as γ-glutamylcysteine synthetase)[@anderson2015].

...

Glutathione Synthetase (GSS)

Overview

Glutathione is the critical tripeptide (γ-glutamyl-cysteinyl-glycine) that serves as:

The primary cellular antioxidant
A detoxifying agent for xenobiotics and heavy metals
A regulator of redox signaling
A cofactor for various enzymes

GSS deficiency leads to severe metabolic and neurological consequences, demonstrating the essential nature of this enzyme. In neurodegenerative diseases, GSS function is often compromised, contributing to oxidative stress and disease progression[@raza2018].

Structure

Enzyme Architecture

GSS is a homodimeric enzyme with the following structural features:

Each Subunit Contains:

N-terminal domain: Involved in γ-glutamylcysteine binding
Central ATP-grasp domain: The catalytic core
C-terminal domain: Contains glycine-binding site

Catalytic Mechanism

GSS uses an ATP-dependent mechanism:

ATP binding to the enzyme's active site

Activation of γ-glutamylcysteine through phosphorylation

Glycine addition forming the peptide bond

Release of glutathione and ADP

The reaction:
γ-Glutamylcysteine + Glycine + ATP → Glutathione + ADP + Pi

Active Site Features

Walker A motif (P-loop) for ATP binding
Mg²⁺ requirement for catalysis
Substrate tunnel for sequential binding
Dimer interface required for activity

Normal Function

Glutathione Biosynthesis

GSS plays the final step in GSH synthesis:

Step 1: GCL (glutamate-cysteine ligase)
Glutamate + Cysteine + ATP → γ-Glutamylcysteine + ADP + Pi

Step 2: GSS (glutathione synthetase)
γ-Glutamylcysteine + Glycine + ATP → Glutathione + ADP + Pi

Cellular Roles of Glutathione

Antioxidant Defense:

Directly scavenges reactive oxygen species (ROS)
Regenerates other antioxidants (vitamin C, vitamin E)
Serves as substrate for glutathione peroxidase

Detoxification:

Conjugates xenobiotics for excretion
Protects against heavy metals (mercury, lead, cadmium)
Neutralizes electrophilic compounds

Redox Signaling:

Maintains thiol redox balance
Modulates protein function through S-glutathionylation
Regulates transcription factor activity

Brain-Specific Functions

In neurons and glia:

Protects against excitotoxicity
Maintains mitochondrial function
Supports neurotransmitter synthesis
Enables astrocyte-neuron glutathione shuttle

Role in Neurodegenerative Disease

Parkinson's Disease

GSS dysfunction is strongly implicated in PD pathogenesis:

Evidence:

GSS activity reduced in substantia nigra of PD patients
Glutathione levels severely depleted in PD brain
GSS polymorphisms associated with PD risk

Mechanisms:

Dopaminergic vulnerability: GSH protects dopaminergic neurons from oxidative damage
Mitochondrial dysfunction: GSH deficiency impairs complex I function
α-Synuclein aggregation: Oxidative stress promotes misfolding

The PD GSH Depletion Cascade:
Environmental toxins → Oxidative stress → GSH depletion
↓
GSS dysfunction → Impaired GSH synthesis → Neuronal vulnerability
↓
Dopaminergic neuron loss → Motor symptoms → Parkinson's disease

Alzheimer's Disease

GSS involvement in AD:

Findings:

Reduced GSS activity in AD hippocampus
Decreased GSH levels in AD brain
GSS gene variants may influence AD risk

Mechanisms:

Amyloid toxicity: Aβ induces oxidative stress that depletes GSH
Tau pathology: Hyperphosphorylated tau associated with GSH depletion
Synaptic dysfunction: GSH loss impairs synaptic plasticity
Neuroinflammation: Activated glia consume GSH

Amyotrophic Lateral Sclerosis (ALS)

Evidence:

GSH levels reduced in ALS spinal cord
GSS activity decreased in motor neurons
Oxidative stress markers elevated

Connections:

SOD1 mutations: Cause oxidative stress requiring GSH buffering
Energy failure: Mitochondrial dysfunction increases ROS
Excitotoxicity: Glutamate-induced oxidative stress

Other Neurodegenerative Conditions

Huntington's Disease: GSH depletion in striatum
Multiple Sclerosis: Demyelination associated with GSH deficiency
Friedreich's Ataxia: Frataxin deficiency impairs GSH metabolism

Protein Interactions

| Partner | Interaction | Function |
|---------|-------------|----------|
| GCL (GCLC/GCLM) | Sequential pathway | First step of GSH synthesis |
| Glutathione peroxidase | Substrate provider | ROS detoxification |
| Glutathione reductase | Regeneration | Maintains reduced GSH |
| γ-Glutamyl transpeptidase | GSH metabolism | Extracellular GSH processing |
| Glutathione S-transferases | Substrate | Xenobiotic detoxification |

Therapeutic Implications

Strategies for Enhancing GSS Activity

| Approach | Mechanism | Status |
|----------|-----------|--------|
| Gene therapy | Increase GSS expression | Preclinical |
| Small molecule activators | Direct GSS activation | Research |
| GSH precursors | Increase substrate availability | Clinical |
| N-acetylcysteine | Cysteine delivery | Clinical trials |
| GSH analogs | Antioxidant replacement | Research |

Clinical Applications

Parkinson's Disease:

N-acetylcysteine (NAC) supplementation: Ongoing trials
GSH infusion: Some clinical benefit reported
GSS gene therapy: Preclinical validation

Alzheimer's Disease:

NAC in combination therapy: Phase II trials
GSH prodrugs: Research stage

ALS:

GSH modulation: Multiple trials
Antioxidant approaches: Limited efficacy

Challenges

Blood-brain barrier limits delivery
GSH has poor cellular uptake
Redox balance must be maintained
Timing of intervention critical

Genetic Deficiency

GSS deficiency is a rare autosomal recessive disorder:

Clinical Features:

5-oxoprolinuria (elevated 5-oxoproline in urine)
Metabolic acidosis
Hemolytic anemia
Neurological symptoms (developmental delay, seizures, ataxia)

Treatment:

Sodium bicarbonate for acidosis
Antioxidant supplementation
Avoidance of oxidative stress
Gene therapy (experimental)

Cross-References

[GSS Gene](/genes/gss)
[Glutathione](/mechanisms/glutathione-metabolism)
[Oxidative Stress](/mechanisms/oxidative-stress-neurodegeneration)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[Glutamate-Cysteine Ligase](/proteins/gcl-complex)
[Glutathione Peroxidase](/proteins/glutathione-peroxidase)

Key Publications

[Glutathione metabolism in neurodegeneration (2015)](https://doi.org/10.1016/j.tins.2015.03.005)

[Glutathione synthetase in brain disorders (2018)](https://doi.org/10.1016/j.neuropharm.2018.03.022)

[Glutathione and antioxidant therapy in neurodegenerative disease (2012)](https://doi.org/10.1016/j.pharmthera.2012.04.005)

[Glutathione synthetase deficiency and neurological disease (2019)](https://doi.org/10.1007/s12035-019-01678-5)

External Links

[UniProt: GSS (P16455)](https://www.uniprot.org/uniprot/P16455)
[RCSB PDB: GSS Structures](https://www.ebi.ac.uk/pdbe/alpha/1GSA)
[Gene: GSS (NCBI)](https://www.ncbi.nlm.nih.gov/gene/2937)
[KEGG: Glutathione metabolism](https://www.genome.jp/kegg-pathway/map00480)

References

anderson2015, Glutathione metabolism in neurodegeneration (2015) [1](https://doi.org/10.1016/j.tins.2015.03.005)
aygul2019, Glutathione synthetase deficiency and neurological disease (2019) [1](https://doi.org/10.1007/s12035-019-01678-5)
johnson2012, Glutathione and antioxidant therapy in neurodegenerative disease (2012) [1](https://doi.org/10.1016/j.pharmthera.2012.04.005)
raza2018, Glutathione synthetase in brain disorders (2018) [1](https://doi.org/10.1016/j.neuropharm.2018.03.022)

📖 View canonical wiki page →